Available now: free lab and office space in the Lab Hotel Read more
Inspira Pharmaceuticals joins the Lab Hotel at Stevenage Bioscience Catalyst
Published on 8 Aug 2022
High Commission of Canada and ISED visit CGT Catapult Manufacturing Innovation Centre
Published on 25 Jul 2022
Achilles Therapeutics to lead Horizon Europe-Funded Consortium to Advance Personalized Cell Therapy Manufacturing
Published on 21 Jul 2022
Freeline: New England Journal of Medicine Publishes Positive Long-Term Data on Freeline’s Gene Therapy Candidate FLT180a for People with Hemophilia B
Published on 21 Jul 2022
Revolo Biotherapeutics Awarded Innovation Passport for ‘1805 in the United Kingdom for the Treatment of Moderate to Severe Rheumatoid Arthritis
Published on 14 Jul 2022
Stevenage Bioscience Catalyst – celebrating 10 years of innovation
Published on 11 Jul 2022
Freeline: Positive Initial Clinical Data from the B-LIEVE Dose-Confirmation Trial for FLT180a in Hemophilia B Presented at the International Society on Thrombosis and Haemostasis Congress
Published on 10 Jul 2022
Stevenage Bioscience Catalyst – Developer named for campus expansion
Published on 4 Jul 2022
Cell and Gene Therapy Catapult and the UK Dementia Research Institute announce collaboration to accelerate advancements in gene therapy
Published on 4 Jul 2022
Achilles Therapeutics Appoints James Taylor as Chief Business Officer and Cassian Yee, MD to Scientific Advisory Board
Published on 30 Jun 2022
Cytiva and Bayer to collaborate on allogeneic cell therapy manufacturing platform
Published on 30 Jun 2022
Freeline to Present New Clinical Data for FLT180a in Hemophilia B at International Society on Thrombosis and Haemostasis Congress
Published on 24 Jun 2022
Achilles Therapeutics Recognized with the 2022 PING Innovation Award
Published on 21 Jun 2022
Galecto Announces First Patient Enrolled in Phase 2 Trial of GB1211 in Combination with Atezolizumab for First-Line Treatment of NSCLC
Published on 16 Jun 2022
Promising new asthma medicine ready to enter early clinical trials
Published on 15 Jun 2022
Freeline Initiates Dosing of Second Cohort in B-LIEVE Dose Confirmation Trial of FLT180a in Hemophilia B
Published on 14 Jun 2022
Rentschler Biopharma adds highly experienced executive to team and provides update on progress at Rentschler ATMP
Published on 13 Jun 2022
Autolus Therapeutics Presents Clinical Data Updates at the European Hematology Association Congress
Published on 10 Jun 2022
Galecto to Participate at Jefferies Healthcare Conference
Published on 31 May 2022
LifeArc co-founded company RQ Bio signs licensing agreement with AstraZeneca worth up to $157m plus royalties for monoclonal antibodies against SARS-CoV-2
Published on 17 May 2022
Action Medical Research and LifeArc announce another round of funding to support translational research into children’s rare diseases
Published on 17 May 2022

Copyright © 2022 Stevenage Bioscience Catalyst

Designed and built by Onespacemedia

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.